Cri­net­ics spins out ra­dio­phar­ma ef­forts in­to a new com­pa­ny, high­light­ing the grow­ing field­'s al­lure

Large­ly known for its non­pep­tide small mol­e­cule re­search, Cri­net­ics has been keep­ing its ra­dio­phar­ma work com­par­a­tive­ly un­der wraps. But that changed Mon­day af­ter­noon as the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER